These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38643857)

  • 1. A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice.
    Wang Z; Sun W; Li D; Sun Y; Zhu M; Wang W; Zhang Y; Li E; Yan F; Wang T; Feng N; Yang S; Xia X; Gao Y
    Virus Res; 2024 Jul; 345():199378. PubMed ID: 38643857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models.
    Zhou R; Wang P; Wong YC; Xu H; Lau SY; Liu L; Mok BW; Peng Q; Liu N; Woo KF; Deng S; Tam RC; Huang H; Zhang AJ; Zhou D; Zhou B; Chan CY; Du Z; Yang D; Au KK; Yuen KY; Chen H; Chen Z
    EBioMedicine; 2022 Jan; 75():103762. PubMed ID: 34942445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice.
    Slamanig S; González-Domínguez I; Chang LA; Lemus N; Lai TY; Martínez JL; Singh G; Dolange V; Abdeljawad A; Kowdle S; Noureddine M; Warang P; Singh G; Lee B; García-Sastre A; Krammer F; Schotsaert M; Palese P; Sun W
    EBioMedicine; 2024 Jul; 105():105185. PubMed ID: 38848648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents.
    Bošnjak B; Odak I; Barros-Martins J; Sandrock I; Hammerschmidt SI; Permanyer M; Patzer GE; Greorgiev H; Gutierrez Jauregui R; Tscherne A; Schwarz JH; Kalodimou G; Ssebyatika G; Ciurkiewicz M; Willenzon S; Bubke A; Ristenpart J; Ritter C; Tuchel T; Meyer Zu Natrup C; Shin DL; Clever S; Limpinsel L; Baumgärtner W; Krey T; Volz A; Sutter G; Förster R
    Front Immunol; 2021; 12():772240. PubMed ID: 34858430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2.
    Dulin H; Barre RS; Xu D; Neal A; Vizcarra E; Chavez J; Ulu A; Yang M-S; Khan SR; Wuang K; Bhakta N; Chea C; Wilson EH; Martinez-Sobrido L; Hai R
    J Virol; 2024 Feb; 98(2):e0157123. PubMed ID: 38206036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.
    van der Ley PA; Zariri A; van Riet E; Oosterhoff D; Kruiswijk CP
    Front Immunol; 2021; 12():781280. PubMed ID: 34987509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development.
    Jearanaiwitayakul T; Sunintaboon P; Kittiayuwat A; Limthongkul J; Wathanaphol J; Janhirun Y; Lerdsamran H; Wiriyarat W; Ubol S
    Vaccine; 2024 Jun; 42(17):3664-3673. PubMed ID: 38714446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
    Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
    Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2.
    Huang J; Wang W; Li H; Bai Y; Song Y; Jiao C; Jin H; Huang P; Zhang H; Xia X; Yan F; Li Y; Wang H
    Antiviral Res; 2024 Jul; 227():105905. PubMed ID: 38740191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.
    Americo JL; Cotter CA; Earl PL; Liu R; Moss B
    Proc Natl Acad Sci U S A; 2022 Jun; 119(24):e2202069119. PubMed ID: 35679343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.
    Lu M; Zhang Y; Dravid P; Li A; Zeng C; Kc M; Trivedi S; Sharma H; Chaiwatpongsakorn S; Zani A; Kenney A; Cai C; Ye C; Liang X; Qiu J; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Peeples ME; Kapoor A; Li J
    J Virol; 2021 Sep; 95(20):e0059221. PubMed ID: 34379509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium.
    Marcos-Villar L; Perdiguero B; López-Bravo M; Zamora C; Sin L; Álvarez E; Sorzano CÓS; Sánchez-Cordón PJ; Casasnovas JM; Astorgano D; García-Arriaza J; Anthiya S; Borrajo ML; Lou G; Cuesta B; Franceschini L; Gelpí JL; Thielemans K; Sisteré-Oró M; Meyerhans A; García F; Esteban I; López-Bigas N; Plana M; Alonso MJ; Esteban M; Gómez CE
    Emerg Microbes Infect; 2024 Dec; 13(1):2387906. PubMed ID: 39087555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protective.
    Zhang Y; Chamblee M; Xu J; Qu P; Shamseldin MM; Yoo SJ; Misny J; Thongpan I; Kc M; Hall JM; Gupta YA; Evans JP; Lu M; Ye C; Hsu CC; Liang X; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Dubey P; Peeples ME; Li J
    Nat Commun; 2024 Jul; 15(1):5589. PubMed ID: 38961063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and immunogenicity of SARS-CoV-2 virus-like particle expressed by recombinant baculovirus BacMam.
    Nguyen HT; Falzarano D; Gerdts V; Liu Q
    Microbiol Spectr; 2024 Aug; 12(8):e0095924. PubMed ID: 38916311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1.
    Li X; Xu M; Yang J; Zhou L; Liu L; Li M; Wang S; Liu MQ; Huang Z; Zhang Z; Liu S; Hu Y; Lin H; Liu B; Sun Y; Wu Q; Shi ZL; Lan K; Chen Y; Yan H; Chen YQ
    Signal Transduct Target Ther; 2024 Apr; 9(1):114. PubMed ID: 38678055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters.
    Liu X; Luongo C; Matsuoka Y; Park HS; Santos C; Yang L; Moore IN; Afroz S; Johnson RF; Lafont BAP; Martens C; Best SM; Munster VJ; Hollý J; Yewdell JW; Le Nouën C; Munir S; Buchholz UJ
    Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34876520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19.
    Xu K; An Y; Li Q; Huang W; Han Y; Zheng T; Fang F; Liu H; Liu C; Gao P; Xu S; Liu X; Zhang R; Zhao X; Liu WJ; Bi Y; Wang Y; Zhou D; Wang Q; Hou W; Xia Q; Gao GF; Dai L
    Emerg Microbes Infect; 2021 Dec; 10(1):1574-1588. PubMed ID: 34289779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats.
    Tcheou J; Raskin A; Singh G; Kawabata H; Bielak D; Sun W; González-Domínguez I; Sather DN; García-Sastre A; Palese P; Krammer F; Carreño JM
    Front Immunol; 2021; 12():791764. PubMed ID: 34868082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles Virus-Based Vaccine Expressing Membrane-Anchored Spike of SARS-CoV-2 Inducing Efficacious Systemic and Mucosal Humoral Immunity in Hamsters.
    Yang ZH; Song YL; Pei J; Li SZ; Liu RL; Xiong Y; Wu J; Liu YL; Fan HF; Wu JH; Wang ZJ; Guo J; Meng SL; Chen XQ; Lu J; Shen S
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An influenza virus vector candidate vaccine stably expressing SARS-CoV-2 receptor-binding domain produces high and long-lasting neutralizing antibodies in mice.
    Zhao Y; Zhao L; Li Y; Liu Q; Deng L; Lu Y; Zhang X; Li S; Ge J; Bu Z; Ping J
    Vet Microbiol; 2022 Aug; 271():109491. PubMed ID: 35714529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.